Publication

Multicountry Distribution and Characterization of Extended-spectrum beta-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Trevor Toy, International Vaccine InstituteGi Deok Pak, International Vaccine InstitutePham Duc Trung, University of OxfordJames I Campbell, University of OxfordMuna Ahmed El Tayeb, University of GeziraVera Von Kalckreuth, International Vaccine InstituteJustin Im, International Vaccine InstituteUrsula Panzner, International Vaccine InstituteLigia Maria Cruz Espinoza, International Vaccine InstituteDaniel Eibach, Bernhard Nocht Institute for Tropical MedicineDenise Myriam Dekker, Bernhard Nocht Institute for Tropical MedicineSe Eun Park, International Vaccine InstituteHyon Jin Jeon, International Vaccine InstituteFrank Konings, International Vaccine InstituteOndari D Mogeni, International Vaccine InstituteLeonard Cosmas, Centers for Disease Control and PreventionMorten Bjerregaard-Andersen, Bandim Health ProjectNagla Gasmelseed, University of GeziraJulian T Hertz, Kilimanjaro Christian Medical CentreRobert F Breiman, Emory University
Language
  • English
Date
  • 2019-11-15
Publisher
  • Oxford University Press (OUP): Policy B - Oxford Open Option C
Publication Version
Copyright Statement
  • © 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1058-4838
Volume
  • 69
Issue
  • Supplement_6
Start Page
  • S449
End Page
  • S458
Grant/Funding Information
  • This article was published as part of the supplement “Severe Typhoid Fever in Africa (SETA) Program” sponsored by the International Vaccine Institute.
  • The International Vaccine Institute acknowledges its donors including the Republic of Korea and the Swedish International Development Cooperation Agency.
  • This research was funded by the Bill & Melinda Gates Foundation (OPP1127988).
  • This publication was made possible through a grant from the Bill & Melinda Gates Foundation (OPP1201031).
Supplemental Material (URL)
Abstract
  • Background: Antimicrobial resistance (AMR) is a major global health concern, yet, there are noticeable gaps in AMR surveillance data in regions such as sub-Saharan Africa. We aimed to measure the prevalence of extended-spectrum β-lactamase (ESBL) producing Gram-negative bacteria in bloodstream infections from 12 sentinel sites in sub-Saharan Africa. Methods: Data were generated during the Typhoid Fever Surveillance in Africa Program (TSAP), in which standardized blood cultures were performed on febrile patients attending 12 health facilities in 9 sub-Saharan African countries between 2010 and 2014. Pathogenic bloodstream isolates were identified at the sites and then subsequently confirmed at a central reference laboratory. Antimicrobial susceptibility testing, detection of ESBL production, and conventional multiplex polymerase chain reaction (PCR) testing for genes encoding for β-lactamase were performed on all pathogens. Results: Five hundred and five pathogenic Gram-negative bloodstream isolates were isolated during the study period and available for further characterization. This included 423 Enterobacteriaceae. Phenotypically, 61 (12.1%) isolates exhibited ESBL activity, and genotypically, 47 (9.3%) yielded a PCR amplicon for at least one of the screened ESBL genes. Among specific Gram-negative isolates, 40 (45.5%) of 88 Klebsiella spp., 7 (5.7%) of 122 Escherichia coli, 6 (16.2%) of 37 Acinetobacter spp., and 2 (1.3%) of 159 of nontyphoidal Salmonella (NTS) showed phenotypic ESBL activity. Conclusions: Our findings confirm the presence of ESBL production among pathogens causing bloodstream infections in sub-Saharan Africa. With few alternatives for managing ESBL-producing pathogens in the African setting, measures to control the development and proliferation of AMR organisms are urgently needed.
Author Notes
  • F. Marks, Public Health, Access and Vaccine Epidemiology Unit,International Vaccine Institute, SNU Research Park, 1-Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea (fmarks@ivi.int).
Keywords
Research Categories
  • Health Sciences, Public Health
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items